sodium zirconium cyclosilicate sold brand name lokelma medication used treat high blood onset effects occurs one six taken common side effects include swelling low blood use likely safe pregnancy works binding potassium ions gastrointestinal tract lost sodium zirconium cyclosilicate approved medical use european union united states developed sodium zirconium cyclosilicate used treat high blood onset effects occurs one six zirconium silicate zirconium silicates extensively used medical dental applications proven zirconium silicates screened iterative optimization process selectively captures potassium ions presumably mimicking actions physiologic potassium inorganic cation exchanger crystalline high capacity entrap monovalent cations specifically potassium ammonium ions gi tract hyperkalemia rare among otherwise among hospital rates common causes include kidney failure hypoaldosteronism number medications also cause high blood potassium including spironolactone nsaids angiotensin converting enzyme universally accepted definition level hyperkalemia mild moderate however hyperkalemia causes ecg change considered medical due risk potentially fatal abnormal heart rhythms treated potassium levels greater mmoll absence ecg changes managed several approaches used treat approved potassium binders united states include patiromer sodium polystyrene hyperkalemia particularly severe marker increased risk however disagreement regarding whether modestly elevated levels directly causes problems one viewpoint mild moderate hyperkalemia secondary effect denotes underlying medical accordingly problems proximate ultimate causes united states regulatory approval rejected food drug administration fda may due issues associated may fda approved sodium zirconium cyclosilicate treatment adults first practically synthesized uop late reference zirconium silicate zirconium germate molecular sieves process using us patent recognition unique ion exchange properties potential use remove toxins body identified shortly thereafter process removing toxins bodily fluids using zirconium titanium microporous compositions us patent one review found decrease potassium meql one hour meql appears effective people chronic kidney disease diabetes heart use studied httpsenwikipediaorgwikisodiumzirconiumcyclosilicate